NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $75.29, above its previous 52-week high of $75.20 with 151,649 shares traded as of 12:51 p.m. ET. Average volume has been 334,300 shares over the past 30 days.
Mednax has a market cap of $3.6 billion and is part of the
industry. Shares are up 10.4% year to date as of the close of trading on Thursday.
MEDNAX, Inc., through its subsidiary, Pediatrix Medical Group, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty and anesthesia physician services in the United States and Puerto Rico. The company has a P/E ratio of 17.1, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Practice your MD trading strategies and win cash in our stock game.
TheStreet Ratings rates Mednax as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and compelling growth in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full
52-week high stocks
or get investment ideas from our